(CVGW) Calavo Growers - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1282461052
Avocados, Guacamole, Tomatoes, Papayas
Dividends
| Dividend Yield | 3.87% |
| Yield on Cost 5y | 1.24% |
| Yield CAGR 5y | -18.80% |
| Payout Consistency | 96.0% |
| Payout Ratio | 61.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 41.8% |
| Value at Risk 5%th | 58.3% |
| Relative Tail Risk | -15.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.46 |
| Alpha | -29.01 |
| CAGR/Max DD | -0.28 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.491 |
| Beta | 0.216 |
| Beta Downside | 0.189 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.81% |
| Mean DD | 25.79% |
| Median DD | 27.54% |
Description: CVGW Calavo Growers October 24, 2025
Calavo Growers, Inc. (NASDAQ: CVGW) is a vertically integrated distributor of fresh avocados, prepared avocado products, and other perishable items, serving grocery, food-service, club, and wholesale channels worldwide. The business is split into two segments-Grown (raw fruit sourcing and distribution) and Prepared (guacamole, avocado pulp, and ready-to-eat items)-and markets its portfolio under a suite of trademarks including Calavo, Avo Fresco, and RIPE NOW!.
Key operational metrics that drive Calavo’s performance include avocado volume (≈ 1.2 million cases / yr in 2023), average selling price (ASP) which tracks Mexican avocado spot prices, and gross margin on prepared products (historically 30-35% vs ≈ 20% on raw fruit). Seasonal supply constraints in Mexico, freight-cost volatility, and U.S. labor-rate inflation are the primary macro-economic levers affecting earnings.
Sector-wide, per-capita avocado consumption in the United States has risen ~ 4% YoY over the past five years, while retail demand for clean-label, ready-to-eat guacamole continues to outpace the broader packaged-foods index, supporting Calavo’s shift toward higher-margin prepared offerings.
For a deeper quantitative breakdown of CVGW’s valuation metrics, the ValueRay platform offers a transparent, data-driven model worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (19.9m TTM) > 0 and > 6% of Revenue (6% = 41.6m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 5.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 12.96% (prev 16.61%; Δ -3.65pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 30.1m > Net Income 19.9m (YES >=105%, WARN >=100%) |
| Net Debt (-60.3m) to EBITDA (30.1m) ratio: -2.00 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (17.9m) change vs 12m ago 0.32% (target <= -2.0% for YES) |
| Gross Margin 9.85% (prev 9.14%; Δ 0.71pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 202.9% (prev 191.6%; Δ 11.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 17.68 (EBITDA TTM 30.1m / Interest Expense TTM 890.0k) >= 6 (WARN >= 3) |
Altman Z'' 3.77
| (A) 0.30 = (Total Current Assets 159.1m - Total Current Liabilities 69.2m) / Total Assets 301.2m |
| (B) 0.09 = Retained Earnings (Balance) 27.6m / Total Assets 301.2m |
| (C) 0.05 = EBIT TTM 15.7m / Avg Total Assets 341.8m |
| (D) 1.15 = Book Value of Equity 27.6m / Total Liabilities 24.0m |
| Total Rating: 3.77 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.01
| 1. Piotroski 7.0pt |
| 2. FCF Yield 9.25% |
| 3. FCF Margin 4.13% |
| 4. Debt/Equity 0.02 |
| 5. Debt/Ebitda -2.00 |
| 6. ROIC - WACC (= 2.94)% |
| 7. RoE 9.76% |
| 8. Rev. Trend -77.99% |
| 9. EPS Trend 34.17% |
What is the price of CVGW shares?
As of December 07, 2025, the stock is trading at USD 20.67 with a total of 223,107 shares traded.
Over the past week, the price has changed by +0.88%, over one month by -7.81%, over three months by -23.36% and over the past year by -18.80%.
Over the past week, the price has changed by +0.88%, over one month by -7.81%, over three months by -23.36% and over the past year by -18.80%.
Is CVGW a buy, sell or hold?
Calavo Growers has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy CVGW.
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CVGW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32.5 | 57.2% |
| Analysts Target Price | 32.5 | 57.2% |
| ValueRay Target Price | 19.3 | -6.7% |
CVGW Fundamental Data Overview December 03, 2025
Market Cap USD = 369.7m (369.7m USD * 1.0 USD.USD)
P/E Trailing = 27.6133
P/E Forward = 18.3486
P/S = 0.533
P/B = 1.7722
P/EG = 1.66
Beta = 0.367
Revenue TTM = 693.7m USD
EBIT TTM = 15.7m USD
EBITDA TTM = 30.1m USD
Long Term Debt = 24.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.48m USD (from shortTermDebt, last quarter)
Debt = 3.48m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -60.3m USD (from netDebt column, last quarter)
Enterprise Value = 309.5m USD (369.7m + Debt 3.48m - CCE 63.8m)
Interest Coverage Ratio = 17.68 (Ebit TTM 15.7m / Interest Expense TTM 890.0k)
FCF Yield = 9.25% (FCF TTM 28.6m / Enterprise Value 309.5m)
FCF Margin = 4.13% (FCF TTM 28.6m / Revenue TTM 693.7m)
Net Margin = 2.87% (Net Income TTM 19.9m / Revenue TTM 693.7m)
Gross Margin = 9.85% ((Revenue TTM 693.7m - Cost of Revenue TTM 625.4m) / Revenue TTM)
Gross Margin QoQ = 10.18% (prev 9.49%)
Tobins Q-Ratio = 1.03 (Enterprise Value 309.5m / Total Assets 301.2m)
Interest Expense / Debt = 5.72% (Interest Expense 199.0k / Debt 3.48m)
Taxrate = -26.02% (negative due to tax credits) (-1.81m / 6.95m)
NOPAT = 19.8m (EBIT 15.7m * (1 - -26.02%)) [negative tax rate / tax credits]
Current Ratio = 2.30 (Total Current Assets 159.1m / Total Current Liabilities 69.2m)
Debt / Equity = 0.02 (Debt 3.48m / totalStockholderEquity, last quarter 206.4m)
Debt / EBITDA = -2.00 (Net Debt -60.3m / EBITDA 30.1m)
Debt / FCF = -2.11 (Net Debt -60.3m / FCF TTM 28.6m)
Total Stockholder Equity = 203.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.60% (Net Income 19.9m / Total Assets 301.2m)
RoE = 9.76% (Net Income TTM 19.9m / Total Stockholder Equity 203.7m)
RoCE = 6.91% (EBIT 15.7m / Capital Employed (Equity 203.7m + L.T.Debt 24.2m))
RoIC = 9.75% (NOPAT 19.8m / Invested Capital 203.3m)
WACC = 6.81% (E(369.7m)/V(373.2m) * Re(6.81%) + D(3.48m)/V(373.2m) * Rd(5.72%) * (1-Tc(-0.26)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.37%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈23.3m ; Y1≈15.3m ; Y5≈6.98m
Fair Price DCF = 7.69 (DCF Value 137.3m / Shares Outstanding 17.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 34.17 | EPS CAGR: 1.56% | SUE: -1.87 | # QB: 0
Revenue Correlation: -77.99 | Revenue CAGR: -10.71% | SUE: -1.09 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.40 | Chg30d=+0.028 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-10-31): EPS=1.82 | Chg30d=-0.060 | Revisions Net=+0 | Growth EPS=+9.6% | Growth Revenue=+10.7%
P/E Trailing = 27.6133
P/E Forward = 18.3486
P/S = 0.533
P/B = 1.7722
P/EG = 1.66
Beta = 0.367
Revenue TTM = 693.7m USD
EBIT TTM = 15.7m USD
EBITDA TTM = 30.1m USD
Long Term Debt = 24.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.48m USD (from shortTermDebt, last quarter)
Debt = 3.48m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -60.3m USD (from netDebt column, last quarter)
Enterprise Value = 309.5m USD (369.7m + Debt 3.48m - CCE 63.8m)
Interest Coverage Ratio = 17.68 (Ebit TTM 15.7m / Interest Expense TTM 890.0k)
FCF Yield = 9.25% (FCF TTM 28.6m / Enterprise Value 309.5m)
FCF Margin = 4.13% (FCF TTM 28.6m / Revenue TTM 693.7m)
Net Margin = 2.87% (Net Income TTM 19.9m / Revenue TTM 693.7m)
Gross Margin = 9.85% ((Revenue TTM 693.7m - Cost of Revenue TTM 625.4m) / Revenue TTM)
Gross Margin QoQ = 10.18% (prev 9.49%)
Tobins Q-Ratio = 1.03 (Enterprise Value 309.5m / Total Assets 301.2m)
Interest Expense / Debt = 5.72% (Interest Expense 199.0k / Debt 3.48m)
Taxrate = -26.02% (negative due to tax credits) (-1.81m / 6.95m)
NOPAT = 19.8m (EBIT 15.7m * (1 - -26.02%)) [negative tax rate / tax credits]
Current Ratio = 2.30 (Total Current Assets 159.1m / Total Current Liabilities 69.2m)
Debt / Equity = 0.02 (Debt 3.48m / totalStockholderEquity, last quarter 206.4m)
Debt / EBITDA = -2.00 (Net Debt -60.3m / EBITDA 30.1m)
Debt / FCF = -2.11 (Net Debt -60.3m / FCF TTM 28.6m)
Total Stockholder Equity = 203.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.60% (Net Income 19.9m / Total Assets 301.2m)
RoE = 9.76% (Net Income TTM 19.9m / Total Stockholder Equity 203.7m)
RoCE = 6.91% (EBIT 15.7m / Capital Employed (Equity 203.7m + L.T.Debt 24.2m))
RoIC = 9.75% (NOPAT 19.8m / Invested Capital 203.3m)
WACC = 6.81% (E(369.7m)/V(373.2m) * Re(6.81%) + D(3.48m)/V(373.2m) * Rd(5.72%) * (1-Tc(-0.26)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.37%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈23.3m ; Y1≈15.3m ; Y5≈6.98m
Fair Price DCF = 7.69 (DCF Value 137.3m / Shares Outstanding 17.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 34.17 | EPS CAGR: 1.56% | SUE: -1.87 | # QB: 0
Revenue Correlation: -77.99 | Revenue CAGR: -10.71% | SUE: -1.09 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.40 | Chg30d=+0.028 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-10-31): EPS=1.82 | Chg30d=-0.060 | Revisions Net=+0 | Growth EPS=+9.6% | Growth Revenue=+10.7%
Additional Sources for CVGW Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle